CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Clinical Laboratory Services Europe

Microbiology and Toxicology

Microbiology and Toxicology form an interdisciplinary scientific taxonomy exploring life at microscopic scale and its chemical hazards. Microbiology studies bacteria, viruses, fungi, and microbes influencing ecosystems and health. Toxicology evaluates adverse effects of substances on biological systems, guiding risk assessment, pharmaceutical safety, environmental regulation, and public health decision-making frameworks globally.

Solutions
Biolab: A Trusted Leader in Bespoke Quality and Safety Testing Solutions
Biolab
A Trusted Leader in Bespoke Quality and Safety Testing Solutions
Jaime Escario, CEO
For over four decades, Biolab has supported clients across the pharmaceutical, medical device and cosmetic industries with specialized analytical testing services that help bring safe and high-quality products to market.
Read more
Leadership Perspective
Point-of-Care Testing for Infectious Diseases - Now and in the Near Future
Amager og Hvidovre Hospital
Point-of-Care Testing for Infectious Diseases - Now and in the Near Future
Gorm Lisby, Section Chief, Department of Clinical Microbiology

Until recently, reliable testing for an acute infection by molecular methods required the patient to be seen by a physician, sampled and the sample to be sent to a microbiology laboratory for testing with a typical total turn-around time to result of more than 24 hours. If a faster result was requested, immunology-based lateral flow near patient testing with results within minutes was an option for some infections, such as Influenza and RSV. However, this came at the cost of inferior sensitivity and specificity compared to molecular-based testing, as highlighted during the COVID-19 pandemic.

Read more
Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/a/microbiology-and-toxicology